Send feedback

AMPD2 p.Arg227Trp

c.679C>T · rs753173769 · VCV2923120

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0912 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.0022%, sas)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
hereditary spastic paraplegia 63

Computational evidence

Protein change
AlphaMissense0.0912likely benign
REVEL0.168moderately benign-leaning
SaProtLLR -11.28damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.7GERP 1.8, phastCons 0.99
Regional constrainto/e 0.89unconstrained · MANE · 1,721 bp · p 0.065 · regional, not allelic
Overall
CADD25.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R281W vs ClinVar R227W) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0022% South Asian · 2/91,090 alleles
Filtering AF 0.000429% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000312%
Overall 0.000868% 14/1,613,744 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,580
South Asiangrpmax 0.0022% 45,545
Remaining individualsnot grpmax-eligible 0.0016% 62,460
European (non-Finnish) 0.000848% 117,990

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AMPD2
Protein
p.Arg227Trp
Coding
c.679C>T
MANE Select
NM_001368809
dbSNP
rs753173769
Type
single nucleotide variant
Location
chr1:109626873 (GRCh38)
Gene constraint
LOEUF 0.705 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.28 · 5 PDB
Full AMPD2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 63 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: pontocerebellar hypoplasia type 9

For Autosomal recessive spastic paraplegia type 63 (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ampd2-p-arg227trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown